Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, T-Cell, Peripheral 1Leukemia 1Hodgkin Disease 1Hemangioma 1

Interventions

Propranolol 9Timolol 5Prednisolone 5Adrenergic beta-Antagonists 3Steroids 2Solutions 2Saline Solution 2Prednisone 2Methylprednisolone 2Adrenal Cortex Hormones 2prednisolone phosphate 1Vincristine 1Urine Specimen Collection 1Tomography, Optical Coherence 1Therapeutics 1Sodium Chloride 1Sirolimus 1Population Groups 1Ointments 1Observation 1Nadolol 1Mupirocin 1Lasers, Semiconductor 1Lasers, Dye 1Imiquimod 1High-Energy Shock Waves 1Hepatectomy 1Gels 1Everolimus 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hemangioma × prednisolone phosphate × Clear all
NCT00967226 2016-02-24

Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas

Children's National Research Institute

Phase 2 Terminated
19 enrolled 25 charts

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡